FG-2216 is primarily utilized in the field of pharmaceutical research, particularly in the development of treatments for neurological disorders. It functions as a potent and selective agonist for specific receptors in the brain, making it a valuable compound for studying conditions such as anxiety, depression, and cognitive impairments. Its ability to modulate receptor activity helps researchers understand the underlying mechanisms of these disorders and explore potential therapeutic interventions. Additionally, FG-2216 has shown promise in preclinical studies for its neuroprotective effects, suggesting potential applications in mitigating neurodegenerative diseases. Its role in advancing neuroscience research underscores its significance in the development of novel treatments for brain-related ailments.